QualityStocksNewsBreaks Archives

MondayJun 29, 2026 10:05 am

QualityStocksNewsBreaks – Swarmer, Inc. (NASDAQ: SWMR) Expands European Software Contract, Adds $1.02 Million in Expected Revenue

Swarmer (NASDAQ: SWMR) announced an amendment to its May 2026 software licensing agreement that increases the total contract value to $3.87 million and is expected to generate an additional $1.02 million in revenue. Under the revised agreement, Czech-based Progress TRW S.R.O. will purchase $1.41 million in SkyKnight software licenses, while Meta Bureau LLC increased its original autonomy software order from $1.38 million to $2.47 million. If all contract options are exercised by Meta Bureau and Progress TRW, the agreement could reach a total value of $14.20 million. The licenses cover Swarmer's software platform, including its operating system, artificial intelligence and…

MondayJun 29, 2026 9:20 am

QualityStocksNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Launches AI Agent Platform for Patient Scheduling and Care Coordination

HealthLynked (OTCQB: HLYK) announced the launch of its next-generation AI Agent Platform, a conversational voice AI solution designed to automate patient scheduling, care coordination and healthcare communications for both patients and providers. The platform supports inbound and outbound voice interactions, enabling AI agents to schedule appointments, navigate physician office phone systems, collect patient and insurance information, perform intake functions, confirm appointments and provide 24/7 answering services for healthcare practices. The company said the platform is designed to help physician practices, accountable care organizations, health systems and insurers improve patient access while reducing administrative burdens and staffing requirements. HealthLynked plans a…

MondayJun 29, 2026 9:10 am

QualityStocksNewsBreaks – Xlife Sciences AG (SIX: XLS) Shareholders Approve All Annual Meeting Proposals

Xlife Sciences (SIX: XLS) announced that shareholders approved all proposals presented at the company's Annual General Meeting, where 3,134,367 voting shares, representing 54.3% of the total share capital, were represented. Chairman David L. Deck said the company strengthened its portfolio during the past year and highlighted the Nasdaq listing of portfolio company Veraxa Biotech (NASDAQ: VRXA) and the planned Landsteiner Scientific platform as key milestones supporting the next phase of growth. The company also emphasized the strategic importance of the planned Landsteiner Scientific platform, which is intended to accelerate the identification and development of novel therapeutic approaches while improving global…

MondayJun 29, 2026 9:00 am

QualityStocksNewsBreaks – Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) Signs Agreement to Acquire Quantum.IQ

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) has entered into a definitive share purchase agreement to acquire Vancouver-based Quantum.IQ Technologies Inc., expanding its technology platform into quantum-resistant cybersecurity, cryptographic intelligence and enterprise security infrastructure modernization. The acquisition is expected to broaden Redwood's exposure beyond AI and operational intelligence into post-quantum cybersecurity, enterprise resilience and critical infrastructure modernization, subject to customary closing conditions and regulatory approvals. Under the agreement, Redwood will issue up to 14,033,558 common shares valued at approximately $2.98 per share,…

MondayJun 29, 2026 9:00 am

Why Market Street Capital Inc. Is ‘One to Watch’

Market Street Capital has evolved from its origins in investor relations into a diversified financial services platform spanning advisory, investment banking, capital raising, restructuring, valuation, and real estate services. The company focuses on established middle-market businesses with enterprise values ranging from $10 million to $1 billion, serving a defined client base that frequently requires sophisticated financial and strategic advisory services. Market Street Capital’s platform combines strategic advisory and transaction execution capabilities, allowing the firm to support clients across multiple stages of the corporate lifecycle. The leadership team brings experience across capital markets, structured finance, mergers and acquisitions, private credit, public…

FridayJun 26, 2026 3:01 pm

QualityStocksNewsBreaks – CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Focuses on Long-Term Opportunity as Market Dynamics Evolve

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX (CSE: CXC) (OTC: CXXMF) is an exploration-stage company advancing the wholly owned Clayton Silver Project in Idaho. The company was featured in a recent article that discussed its positioning to navigate increasing volatility in precious metals markets driven in part by the growing influence of derivatives trading. While derivatives can improve liquidity and provide hedging opportunities, they can also contribute to heightened leverage and skewed prices. Against this backdrop, the company remains focused on advancing its historic Clayton Silver Mine, which it believes could…

FridayJun 26, 2026 2:16 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Expands AI Voice Analytics Beyond Traditional Screening

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) is a biotechnology company commercializing AI-driven voice technology for drug and alcohol intoxication detection. The company was featured in a recent article that discussed its efforts to broaden the scope of its platform with the development of a fatigue prediction model designed for high-risk workplace environments. “The fatigue detection capability is expected to become an additional feature within MindBio’s planned Edge AI Intoxication Detection Kiosks, which are being designed to identify signs of alcohol, drug impairment and fatigue from short voice…

FridayJun 26, 2026 11:39 am

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in NetworkNewsAudio Editorial on DNA Repair Therapies

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced its inclusion in a NetworkNewsAudio Audio Press Release highlighting the company's approach to next-generation DNA repair therapies for cancer. The audio feature, titled "Next-Generation DNA Repair Therapies Open New Frontiers in Oncology," accompanies a previously published editorial examining the emerging opportunity for PNKP inhibitors within the expanding DNA Damage Response ("DDR") oncology market. The feature highlights Onco-Innovations' exclusive global rights to a portfolio of PNKP inhibitor technology, including core inhibitor molecules, nanoparticle drug delivery technology and synthetic lethality applications designed to target cancer cells. The company said this combination of molecular, delivery…

FridayJun 26, 2026 10:15 am

QualityStocksNewsBreaks – Suntex Enterprises Inc. (OTC: SNTX) Highlights Recent Operational and Strategic Milestones

Suntex Enterprises (OTC: SNTX) announced the completion of several strategic initiatives over the past two weeks, including fulfilling commitments under its asset purchase agreement with Golden Triangle Ventures, engaging a PCAOB-registered accounting firm to begin the audit process, appointing independent director Lisa Surnow and advancing plans to qualify for the OTCQB(R) Venture Market, subject to meeting applicable listing and regulatory requirements. The company also reported continued progress on its 100-acre mixed-use South Texas development and expansion of its commercial construction business through subsidiary JA Development & Construction. Suntex said its construction subsidiary has begun work on an approximately $4 million…

FridayJun 26, 2026 10:05 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in NetworkNewsAudio Editorial on Multiple Sclerosis

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced its inclusion in a NetworkNewsAudio Audio Press Release highlighting the company's novel approach to treating multiple sclerosis ("MS"). The audio feature, titled "Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis," accompanies a previously published editorial discussing the growing need for therapies that go beyond symptom management in a global MS therapeutics market projected to reach $38.62 billion by 2030. The feature highlights Quantum BioPharma's lead candidate, Lucid-MS, a patented, first-in-class drug candidate designed…

Site Search

Company Search

Category: QualityStocksNewsBreaks